483
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site)FDA 483 - Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) - April 13, 2018
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Jiangsu Hengrui Medicine Co., LTD., an API and Sterile Drug Manufacturer in Lianyugang, China, revealed two significant observations. The firm was cited for inadequate laboratory controls regarding raw material sampling plans and for insufficient controls over computer systems, leading to concerns about electronic data integrity and unauthorized deletion privileges.
- Inspection Date
- April 13, 2018
- Product Type
- Drugs
Open in Dashboard
ID · 45fdb93b-9fe4-47f6-a5dc-a3e42f8fe357